{"sourcedb":"DevicePMAs@therightstef","sourceid":"P970015_S017","text":"Approval for the interfix(tm) rp threaded fusion device to be also known as the interfix(tm) rp threaded fusion device - reduced profile.  The device will now be marketed under both trade names and will remain indicated for use with autogenous bone braft in patients with degenerative disc disease (ddd) at one level from l2-s1.  These ddd patients may also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  The device is to be implanted via an open anterior approach.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by history and radiographic studies.  These patients should be skeletally mature and have had six months of non-operative treatment.","project":"consensus_PMA_Age_Indications"}